Riferimento:
Hormones (Athens). 2012 Apr-Jun;11(2):199-202.
Autori:
Karapanou O, Tzanela M, Tamouridis N, Tsagarakis S.
Fonte:
Hormones (Athens). 2012 Apr-Jun;11(2):199-202.
Anno:
2012
Azione:
Somministrazione di octreotide come modalità di trattamento efficace nella sindrome spontanea da iperstimolazione ovarica (OHSS) causata da adenomi pituitari con secrezione di gonadotropine.
Target:
Octreotide/iperstimolazione ovarica da adenomi pituitari.
ABSTRACT
We report a young woman with spontaneous ovarian hyperstimulation syndrome (OHSS), headaches, visual field defect and pituitary macroadenoma. She underwent transsphenoidal surgery with remission of OHSS. Immunohistochemical staining was positive for β-FSH and β-LH. Recurrence occurred after four years. The patient was treated with octreotide administration and conventional radiation therapy. Octreotide was effective in normalizing estradiol levels and resolving OHSS. This is a rare description of octreotide administration as an effective treatment modality of OHSS caused by gonadotropin-secreting pituitary adenomas.
Sostanze: